Institutional Trading Of Mirum Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Institutional trading of mirum pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Institutional Trading Of Mirum Pharmaceuticals Today - Breaking & Trending Today

Citigroup Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $38.00

Citigroup Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $38.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Eric Bjerkholt , Stifel Nicolaus , Peter Radovich , Mirae Asset Global Investments Co , Mirum Pharmaceuticals Inc , News Ratings For Mirum Pharmaceuticals Daily , Cantor Fitzgerald , William Blair Investment Management , Analyst Recommendations For Mirum Pharmaceuticals , Mirum Pharmaceuticals Stock Down , Securities Exchange Commission , Mirum Pharmaceuticals Company Profile , Russell Investments Group Ltd , Mirum Pharmaceuticals , China Universal Asset Management Co , Wetzel Investment Advisors Inc , Institutional Trading Of Mirum Pharmaceuticals , Free Report , Pharmaceuticals Stock Down , Get Free Report , Exchange Commission , Blair Investment Management , Investments Group , Asset Global Investments , Universal Asset Management ,

Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week Low at $23.14

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares traded. The stock had previously closed at $24.02. Wall Street Analysts Forecast Growth A number of equities […] ....

United States , Peter Radovich , Eric Bjerkholt , Stifel Nicolaus , Polar Capital Holdings Plc , Cantor Fitzgerald , Genworth Financial Inc , Raymond James Associates , Rafferty Asset Management , Institutional Trading Of Mirum Pharmaceuticals , Charles Schwab Investment Management Inc , Mirum Pharmaceuticals , News Ratings For Mirum Pharmaceuticals Daily , Mirum Pharmaceuticals Inc , Mirum Pharmaceuticals Trading , Get Free Report , Capital Holdings Plc , Asset Management , Schwab Investment Management , Mirum Pharmaceuticals Daily ,

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Peter Radovich Sells 4,303 Shares

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of Mirum Pharmaceuticals stock in a transaction on Monday, March 25th. The stock was sold at an average price of $25.80, for a total transaction of $111,017.40. Following the sale, the chief operating officer now directly owns 29,013 shares of the […] ....

Los Angeles , United States , Peter Radovich , Raymond James , China Universal Asset Management Co , Institutional Trading Of Mirum Pharmaceuticals , Mirum Pharmaceuticals Price Performance , Mirum Pharmaceuticals Inc , Mirum Pharmaceuticals , Los Angeles Capital Management , Royal Bank , Life Insurance Co , Quarter For Mirum Pharmaceuticals , Cantor Fitzgerald , News Ratings For Mirum Pharmaceuticals Daily , Silverarc Capital Management , Get Free Report , Capital Management , Universal Asset Management , Angeles Capital Management , Mirum Pharmaceuticals Daily ,

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Sells $111,017.40 in Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of the firm’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $25.80, for a total value of $111,017.40. Following the completion of the transaction, the chief operating officer now owns 29,013 shares […] ....

United States , Peter Radovich , Raymond James , Wetzel Investment Advisors Inc , Life Insurance Co , Royal Bank , Quarter For Mirum Pharmaceuticals , News Ratings For Mirum Pharmaceuticals Daily , Mirum Pharmaceuticals Company Profile , Cantor Fitzgerald , China Universal Asset Management Co , Institutional Trading Of Mirum Pharmaceuticals , Mirum Pharmaceuticals , Mirum Pharmaceuticals Price Performance , Mirum Pharmaceuticals Inc , Get Free Report , Universal Asset Management , Investment Advisors , Mirum Pharmaceuticals Daily ,

FY2023 EPS Estimates for Mirum Pharmaceuticals, Inc. Decreased by Analyst (NASDAQ:MIRM)

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Equities researchers at HC Wainwright dropped their FY2023 EPS estimates for Mirum Pharmaceuticals in a research note issued on Tuesday, February 27th. HC Wainwright analyst E. Arce now forecasts that the company will earn ($2.44) per share for the year, down from their previous estimate of ($2.13). […] ....

Los Angeles , United States , Peter Radovich , Raymond James , Jolanda Howe , Los Angeles Capital Management , News Ratings For Mirum Pharmaceuticals Daily , Morgan Stanley , Raymond James Associates , Insider Activity At Mirum Pharmaceuticals , Cantor Fitzgerald , Jump Financial , Mirum Pharmaceuticals Stock Down , Securities Exchange Commission , Campbell Co Investment Adviser , Institutional Trading Of Mirum Pharmaceuticals , Rafferty Asset Management , Mirum Pharmaceuticals , Mirum Pharmaceuticals Inc , Jpmorgan Chase Co , Free Report , Mirum Pharmaceutical , Pharmaceuticals Stock Down , Asset Management , Angeles Capital Management , Exchange Commission ,